NCT06100471View on ClinicalTrials.gov

Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling

Enrolling by invitationOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

December 31, 2024

Conditions
EndometriosisHypofertility
Interventions
OTHER

Observational study

Observational study in different tissues in identifing new genetic markers related to endometriosis disease

Trial Locations (1)

00138

Eurofins Genoma, Rome

Sponsors

Lead Sponsor

Eurofins Genoma
All Listed Sponsors
lead

Eurofins Genoma

INDUSTRY